1
|
Sun X, Li Y, Li J, Liang H, Zhang J, Chen X, Li Q, Pang X, Ding Q, Song J, Guo B, Ma B. Bioactive metabolites reveal the therapeutic consistency of epimedii folium from multi-plant sources for the treatment of kidney-yang deficiency. JOURNAL OF ETHNOPHARMACOLOGY 2024; 319:117215. [PMID: 37774896 DOI: 10.1016/j.jep.2023.117215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Revised: 08/31/2023] [Accepted: 09/20/2023] [Indexed: 10/01/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Epimedii Folium (Yin-yang-huo in Chinese), a traditional and commonly used herbal medicine (HM), is a representative of multi-plant sources. To date, little is known about the reasons for similar therapeutic effects of this HM from multi-plant sources. AIM OF THE STUDY To investigate the underlying reasons for the similar pharmacological effects of Epimedii Folium from two botanical sources (Epimedium koreanum Nakai and Epimedium wushanense T. S. Ying). MATERIALS AND METHODS Firstly, the phytochemicals of the extracts of E. koreanum and E. wushanense were systematically analyzed. Meanwhile, their pharmacological effects on kidney-yang deficiency (KYD) syndrome were evaluated in rats induced by hydrocortisone. Subsequently, we proposed a combined effect index (CEI) to assess the effects of two plants on the secretion of testosterone by combing the system exposure of twelve active components in vivo with their regulation activities of testosterone production in vitro. Moreover, the label-free proteomics and Western blot analysis were conducted to evaluate the possible mechanism of Epimedii Folium from two botanical sources. RESULTS E. koreanum and E. wushanense exhibited similar pharmacological effects on KYD syndrome with promoting the mating behaviors and testosterone levels of rats, although there is a certain difference in the main components between two plants. The CEI analysis showed that there was no difference (P > 0.05) in the sum of CEIs of two Epimedium, indicating that their similar therapeutic effects are attributed to bioactive metabolites in vivo. Furthermore, Epimedii Folium can regulate testosterone production in rat Leydig cell via reversing expressions of key steroidogenic enzymes, such as steroidogenic acute regulatory protein (StAR) and 3β-hydroxysteroid dehydrogenase (3β-HSD). CONCLUSION Our results supply critical evidence for the similar pharmacological effects of two Epimedium species, acting by consistent bioactive components directly exposing in vivo, not chemical compositions presenting in herbs. It provides a reasonable scientific basis for understanding of the HMs originated from multi-plant sources for the same clinical application.
Collapse
Affiliation(s)
- Xinguang Sun
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Yingfei Li
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
| | - Juan Li
- Hubei University of Chinese Medicine, Wuhan, 430065, China.
| | - Haizhen Liang
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Jie Zhang
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Xiaojuan Chen
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Qi Li
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Xu Pang
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Qianzhi Ding
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Juan Song
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| | - Baolin Guo
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
| | - Baiping Ma
- Beijing Institute of Radiation Medicine, Beijing, 100850, China.
| |
Collapse
|
2
|
Simultaneous determination of multiple constituents of Qi-Lin pill by UPLC-MS/MS: Applications to pharmacokinetics and testicular tissue distribution in rats. J Pharm Biomed Anal 2022; 223:115157. [DOI: 10.1016/j.jpba.2022.115157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 10/31/2022] [Accepted: 11/08/2022] [Indexed: 11/11/2022]
|
3
|
Liu R, Su C, Xu Y, Shang K, Sun K, Li C, Lu J. Identifying potential active components of walnut leaf that action diabetes mellitus through integration of UHPLC-Q-Orbitrap HRMS and network pharmacology analysis. JOURNAL OF ETHNOPHARMACOLOGY 2020; 253:112659. [PMID: 32058009 DOI: 10.1016/j.jep.2020.112659] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2019] [Revised: 01/28/2020] [Accepted: 02/05/2020] [Indexed: 06/10/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Walnut leaf (WL) is a hypoglycemic herbal medication with blood glucose-lowering activity that can affect diabetes mellitus (DM). However, the active components of WL and the mechanisms by which these compounds affect DM are unclear. AIM OF STUDY This study aimed to determine these effective ingredients and elucidate the potential mechanisms by which they affect DM via ultra-high performance liquid chromatography-hybrid quadrupole-Orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) coupled with network pharmacology analysis. MATERIALS AND METHODS First, UHPLC-Q-Orbitrap HRMS was utilized to identify components of WL. Second, the putative targets of the components were identified and predicted based on chemical similarity and online databases. Third, the key candidate targets and potential active components were identified through topological analysis of a component-disease target interaction network. Finally, interactions between active components and therapeutic targets were confirmed by molecular docking analysis. RESULTS One hundred and thirty components were identified in WL, among which 38 were considered potentially bioactive, as they showed hypoglycemic effects. Among these 38, 8 key active components possessed high similarities and shared 4 targets with approved drugs. These findings were confirmed by molecular docking analysis. CONCLUSION The approach combining UHPLC-Q-Orbitrap HRMS with network pharmacology analysis is a rapid and effective tool to identify potentially bioactive constituents in medicinal plants and prescriptions.
Collapse
Affiliation(s)
- Rongxia Liu
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
| | - Chaonan Su
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
| | - Yumeng Xu
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
| | - Kangle Shang
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
| | - Kang Sun
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
| | - Caihong Li
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
| | - Jing Lu
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.
| |
Collapse
|
4
|
Simultaneous determination of multiple components in rat plasma and pharmacokinetic studies at a pharmacodynamic dose of Xian-Ling-Gu-Bao capsule by UPLC-MS/MS. J Pharm Biomed Anal 2020; 177:112836. [DOI: 10.1016/j.jpba.2019.112836] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2019] [Revised: 07/08/2019] [Accepted: 08/24/2019] [Indexed: 01/08/2023]
|
5
|
Wang HC, Bao YR, Wang S, Li TJ, Meng XS. Simultaneous determination of eight bioactive components of Cirsium setosum flavonoids in rat plasma using triple quadrupole LC/MS and its application to a pharmacokinetic study. Biomed Chromatogr 2019; 33:e4632. [PMID: 31264241 DOI: 10.1002/bmc.4632] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Revised: 06/14/2019] [Accepted: 06/24/2019] [Indexed: 12/14/2022]
Abstract
Cirsium setosum (Willd.) MB. has been reported to exert significant anti-hemorrhagic, anti-inflammation, antimicrobial, sedative and detoxicating efficacy. It has been widely used to treat gastrointestinal bleeding, uterine bleeding, infectious hepatitis and cardiovascular disease in China. Recent studies have shown that flavonoids are the main active components in C. setosum. Nevertheless, to the best of our knowledge, there is no report concerning the simultaneous determinations and pharmacokinetics of constituents in C. setosum flavonoids in rat plasma. In this study, a rapid, sensitive and selective triple quadrupole liquid chromatography-mass spectrometry method was developed to determine eight analytes from the flavonoids of C. setosum in rat plasma. In addition, the pharmacokinetic study of the eight analytes in rats after oral administration of C. setosum flavonoids was successfully completed through this method. According to the pharmacokinetic parameters of the eight analytes, rutin, naringin, quercetin, acacetin, wogonin were the long-acting components of the C. setosum flavonoids, with long elimination time and high bioavailability. Of note, the method developed in this study fills a blank in pharmacokinetic studies of C. setosum flavonoids. Our findings provide valuable views on the understanding of the absorption mechanism of C. setosum flavonoids and their clinical efficacy.
Collapse
Affiliation(s)
- He Chen Wang
- Liaoning University of Traditional Chinese Medicine-Agilent Technologies Modern TCM and Multi-omics Research Collaboration Lab, Dalian, P. R. China.,Liaoning University of Traditional Chinese Medicine, Dalian, P. R. China
| | - Yong Rui Bao
- Liaoning University of Traditional Chinese Medicine-Agilent Technologies Modern TCM and Multi-omics Research Collaboration Lab, Dalian, P. R. China.,Liaoning University of Traditional Chinese Medicine, Dalian, P. R. China
| | - Shuai Wang
- Liaoning University of Traditional Chinese Medicine-Agilent Technologies Modern TCM and Multi-omics Research Collaboration Lab, Dalian, P. R. China.,Liaoning University of Traditional Chinese Medicine, Dalian, P. R. China
| | - Tian Jiao Li
- Liaoning University of Traditional Chinese Medicine-Agilent Technologies Modern TCM and Multi-omics Research Collaboration Lab, Dalian, P. R. China.,Liaoning University of Traditional Chinese Medicine, Dalian, P. R. China
| | - Xian Sheng Meng
- Liaoning University of Traditional Chinese Medicine-Agilent Technologies Modern TCM and Multi-omics Research Collaboration Lab, Dalian, P. R. China.,Liaoning University of Traditional Chinese Medicine, Dalian, P. R. China
| |
Collapse
|
6
|
Shao Y, Zhang W, Tong L, Huang J, Li D, Nie W, Zhu Y, Li Y, Lu T. Simultaneous determination of eight bioactive components of Qishen Yiqi dripping pills in rat plasma using UFLC-MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr 2017; 31. [PMID: 28146302 DOI: 10.1002/bmc.3941] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2016] [Revised: 01/15/2017] [Accepted: 01/29/2017] [Indexed: 12/16/2023]
Abstract
In this study, a rapid and reliable ultra-fast liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous determination of eight active ingredients, including astragaloside IV, ononin, tanshinol, protocatechualdehyde, protocatechuic acid, salvianolic acid D, rosmarinic acid and ginsenoside Rg1 , in rat plasma. The plasma samples were pretreated by protein precipitation with acetonitrile. Chromatographic separation was performed on a Waters Acquity UPLC® BEH C18 column (1.7 μm particles, 2.1 × 100 mm). The mobile phase consisted of 0.1% aqueous formic acid (A)-acetonitrile with 0.1% formic acid (B) at a flow rate of 0.4 mL/min. Quantification was performed on a triple quadruple tandem mass spectrometry with electrospray ionization by multiple reaction monitoring both in the negative and in the positive ion mode. The lower limit of quantification of tanshinol was 2.0 ng/mL and the others were 5.0 ng/mL. The extraction recoveries, matrix effects, intra- and inter-day precision and accuracy of eight tested components were all within acceptable limits. The validated method was successfully applied to the pharmacokinetic study of the eight active constituents after intragastric administration of three doses (1.0, 3.0, 6.0 g/kg body weight) of Qishen Yiqi Dripping Pills to rats.
Collapse
Affiliation(s)
- Yaping Shao
- School of Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China
| | - Wen Zhang
- Tasly Academy, Tianjin Tasly Holding Group Co. Ltd, Tianjin, People's Republic of China
- Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China
- Research and Development Center of TCM, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin, People's Republic of China
| | - Ling Tong
- Tasly Academy, Tianjin Tasly Holding Group Co. Ltd, Tianjin, People's Republic of China
| | - Jingyi Huang
- Tasly Academy, Tianjin Tasly Holding Group Co. Ltd, Tianjin, People's Republic of China
| | - Dongxiang Li
- Tasly Academy, Tianjin Tasly Holding Group Co. Ltd, Tianjin, People's Republic of China
| | - Wei Nie
- Tasly Academy, Tianjin Tasly Holding Group Co. Ltd, Tianjin, People's Republic of China
| | - Yan Zhu
- Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China
- Research and Development Center of TCM, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin, People's Republic of China
| | - Yunfei Li
- Tasly Academy, Tianjin Tasly Holding Group Co. Ltd, Tianjin, People's Republic of China
| | - Tao Lu
- School of Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China
| |
Collapse
|
7
|
Zhong Q, Shi Z, Zhang L, Zhong R, Xia Z, Wang J, Wu H, Jiang Y, Sun E, Wei Y, Feng L, Zhang Z, Liu D, Song J, Jia X. The potential of Epimedium koreanum Nakai for herb–drug interaction. J Pharm Pharmacol 2017; 69:1398-1408. [PMID: 28653752 DOI: 10.1111/jphp.12773] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2017] [Accepted: 05/28/2017] [Indexed: 12/30/2022]
Abstract
Abstract
Objectives
This study aims to investigate potential herb–drug interactions (HDI) of Epimedium koreanum Nakai.
Methods
Human liver microsomes (HLMs) were used to determine the enzyme kinetics of the major human cytochrome P450s (CYPs). Inducible potential of E. koreanum on CYP1A2, 2B6, 2C19 and 3A4 activities of human primary hepatocytes was also examined.
Key findings
Ethanol extract of E. koreanum showed direct inhibitory potency for CYP1A2 (IC50 = 121.8 μg/ml, Ki = 110.7 ± 36.8 μg/ml) and CYP2B6 (IC50 = 59.5 μg/ml, Ki = 18.1 ± 2.9 μg/ml). For CYP2C9, 2C19, 2D6, 2E1 and 3A4, only negligible effect was observed. Time-dependent (irreversible) inhibition by E. koreanum was observed for CYP1A2 (KI = 32.9 ± 18.4 μg/ml, kinact = 0.031 ± 0.006 min−1). However, ethanol extract of E. koreanum (1.5–150 μg/ml) did not change the activity or mRNA expressions for CYP3A4, 1A2, 2C19 and 2B6.
Conclusions
The ethanol extract of E. koreanum is not likely to cause HDI via inducing the major human CYPs. But the potential for interactions between E. koreanum extract and substrates of CYP1A2 or 2B6 cannot be overlooked.
Collapse
Affiliation(s)
- Qingxiang Zhong
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
- Key Laboratory of Delivery Systems of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing, Jiangsu, China
| | - Ziqi Shi
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Li Zhang
- Clinical Laboratory, Jiangsu Provincial Academy of Chinese Medicine, Nanjing, Jiangsu, China
| | - Rongling Zhong
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Zhi Xia
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Jing Wang
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Hao Wu
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Yutong Jiang
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - E Sun
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Yingjie Wei
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Liang Feng
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Zhenhai Zhang
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Dan Liu
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
| | - Jie Song
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
- Key Laboratory of Delivery Systems of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing, Jiangsu, China
| | - Xiaobin Jia
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
- Key Laboratory of Delivery Systems of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing, Jiangsu, China
| |
Collapse
|
8
|
Wang L, Hong X, Yao Z, Dai Y, Zhao G, Qin Z, Wu B, Gonzalez FJ, Yao X. Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes. Xenobiotica 2017; 48:357-367. [PMID: 28443723 DOI: 10.1080/00498254.2017.1323139] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
1. Icaritin is a natural flavonoid with anti-osteoporosis activity. This study aimed to characterize icaritin glucuronidation by pooled human liver microsomes (HLM) and pooled human intestine microsomes (HIM), and to determine the contribution of individual UDP-glucuronosyltrans-ferase (UGT) enzyme to icaritin glucuronidation. 2. Glucuronidation rates were determined by incubating icaritin with uridine diphosphate glucuronic acid (UDPGA)-supplemented microsomes. Kinetic parameters were derived by appropriate model fitting. Relative activity factors and activity correlation analysis were performed to identify main UGT isoforms. 3. UGT1A3, 1A7, 1A8, 1A9 and 2B7 were mainly responsible for catalyzing the formation of two glucuronides (G1 and G2). Icaritin 3-O-glucuronidation (G1) was significantly correlated with Chenodeoxycholic acid (CDCA) glucuronidation (r = 0.787, p = 0.002), propofol glucuronidation (r = 0.661, p = 0.019) and Zidovudine (AZT) glucuronidation (r = 0.805, p = 0.002). Similarly, icaritin 7-O-glucuronidation (G2) was also correlated with CDCA glucuronidation (r = 0.640, p = 0.025), propofol glucuronidation (r = 0.592, p = 0.043) and AZT glucuronidation (r = 0.661, p = 0.019). In addition, UGT1A3, 1A9 and 2B7 contributed 37.5, 33.8 and 21.3% for G1 in pooled HLM, respectively. Also, UGT1A3, 1A9 and 2B7 contributed 34.3, 20.0 and 8.6% for G2 in pooled HLM, respectively. 4. Icaritin was subjected to significant glucuronidation, wherein UGT1A3, 1A7, 1A8, 1A9 and 2B7 were main contributing enzymes.
Collapse
Affiliation(s)
- Li Wang
- a College of Pharmacy, Jinan University , Guangzhou , P.R. China.,b Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University , Guangzhou , P.R. China
| | - Xiaodan Hong
- a College of Pharmacy, Jinan University , Guangzhou , P.R. China.,b Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University , Guangzhou , P.R. China
| | - Zhihong Yao
- a College of Pharmacy, Jinan University , Guangzhou , P.R. China.,b Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University , Guangzhou , P.R. China
| | - Yi Dai
- a College of Pharmacy, Jinan University , Guangzhou , P.R. China.,b Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University , Guangzhou , P.R. China
| | - Guoping Zhao
- c Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University , Guangzhou , P.R. China , and
| | - Zifei Qin
- a College of Pharmacy, Jinan University , Guangzhou , P.R. China.,b Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University , Guangzhou , P.R. China.,c Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University , Guangzhou , P.R. China , and
| | - Baojian Wu
- a College of Pharmacy, Jinan University , Guangzhou , P.R. China.,b Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University , Guangzhou , P.R. China.,c Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University , Guangzhou , P.R. China , and
| | - Frank J Gonzalez
- d Laboratory of Metabolism , Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda , MD , USA
| | - Xinsheng Yao
- a College of Pharmacy, Jinan University , Guangzhou , P.R. China.,b Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University , Guangzhou , P.R. China.,c Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University , Guangzhou , P.R. China , and
| |
Collapse
|
9
|
Bai L, Han Y, Xu P, Xia B, Zhao Y, Li X, Xue M. Plasma pharmacokinetics and brain distribution kinetics of lapachol in rats using LC-MS and microdialysis techniques. RSC Adv 2017. [DOI: 10.1039/c7ra07369k] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The objective of this paper was to investigate the plasma pharmacokinetics and brain distribution kinetics of lapachol in rats.
Collapse
Affiliation(s)
- Lu Bai
- Department of Pharmacology
- Beijing Laboratory for Biomedical Detection Technology and Instrument
- School of Basic Medical Sciences
- Capital Medical University
- Beijing 100069
| | - Ying Han
- College of Medical Sciences
- Inner Mongolia University for Nationalities
- Huhehaote
- China
| | - Pingxiang Xu
- Department of Pharmacology
- Beijing Laboratory for Biomedical Detection Technology and Instrument
- School of Basic Medical Sciences
- Capital Medical University
- Beijing 100069
| | - Binbin Xia
- Department of Pharmacology
- Beijing Laboratory for Biomedical Detection Technology and Instrument
- School of Basic Medical Sciences
- Capital Medical University
- Beijing 100069
| | - Yuming Zhao
- Department of Pharmacology
- Beijing Laboratory for Biomedical Detection Technology and Instrument
- School of Basic Medical Sciences
- Capital Medical University
- Beijing 100069
| | - Xiaorong Li
- Department of Pharmacology
- Beijing Laboratory for Biomedical Detection Technology and Instrument
- School of Basic Medical Sciences
- Capital Medical University
- Beijing 100069
| | - Ming Xue
- Department of Pharmacology
- Beijing Laboratory for Biomedical Detection Technology and Instrument
- School of Basic Medical Sciences
- Capital Medical University
- Beijing 100069
| |
Collapse
|
10
|
Hao DC, Yang L. Drug metabolism and disposition diversity of Ranunculales phytometabolites: a systems perspective. Expert Opin Drug Metab Toxicol 2016; 12:1047-65. [DOI: 10.1080/17425255.2016.1201068] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Da Cheng Hao
- Biotechnology Institute, School of Environment and Chemical Engineering, Dalian Jiaotong University, Dalian, China
| | - Ling Yang
- Pharmaceutical resource discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China
| |
Collapse
|